Study: SBRT Delivers 98.6% Cure Rate at Five-Year Followup

A five-year study showed that stereotactic body radiation therapy to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.

The study, the first trial to publish five-year results from SBRT treatment for prostate cancer, according to the researchers, found a 98.6 percent cure rate with SBRT.